References
- Ludwig J, Viggiano T R, McGill D B, Oh B J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434–438
- Neuschwander-Tetri B A, Caldwell S H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202–1219
- Powell E E, Cooksley W G, Hanson R, Searle J, Halliday J W, Powell L W. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990; 11: 74–80
- Clark J M, Diehl A M. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000–3004
- Day C P, James O FW. Steatohepatitis. A tale of two ‘hits’?. Gastroenterology 1998; 114: 842–845
- Farrell G C. Drugs and steatohepatitis. Semin. Liver Disease 2003; 22: 185–194
- Itoh S, Igarashi M, Tsukada Y. Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy. Acta Hepatol Gastroenterol 1977; 24: 415–418
- Nanki T, Koike R, Miyasaka N. Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis. Am J Gastroenterol 1999; 94: 3379
- Dourakis S P, Sevastianos V A, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol 2002; 97: 1074–1075
- Caldwell S H, Hespenheide E E. Subacute liver failure in obese women. Am J Gastroenterol 2002; 97: 2058–2062
- Kamata Y, Kamimura T, Yoshio T, Hirata D, Masuyama J, Isoda N, et al. Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report. Ryumachi 2003; 43: 667–671
- Candelli M, Nista E C, Pignataro G, Zannoni G, de Pascalis B, Gasbarrini G, Gasbarrini A. Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation. J Intern Med 2003; 253: 391–392
- Yoshida C, Kojima H, Iijima T, Katsura Y, Shimizu S, Suzukawa K, et al. Association of non-alcoholic steatohepatitis (NASH) with chronic neutrophilic leukemia. Eur J Haematol 2004; 72: 225–228